Charles River Laboratories International, Inc.

Charles River Laboratories Beats on EPS, Stock Down 4.66%

Charles River Laboratories reported an EPS of $1.63, exceeding expectations slightly. However, the stock fell by 4.66% following the earnings report, indicating that investors may have been disappointed by the lack of revenue details and guidance. The absence of management commentary could also contribute to investor uncertainty.